354 related articles for article (PubMed ID: 27725289)
1. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Bonacci M; Lens S; Londoño MC; Mariño Z; Cid MC; Ramos-Casals M; Sánchez-Tapias JM; Forns X; Hernández-Rodríguez J
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
4. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
5. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
7. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
Dammacco F; Racanelli V; Russi S; Sansonno D
Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
[TBL] [Abstract][Full Text] [Related]
8. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.
Passerini M; Schiavini M; Magni CF; Landonio S; Niero F; Passerini S; Croci AL; Bolis M; Scalzi V; Gubertini G; Ricci ED; Galli M; Rizzardini G
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1208-1215. PubMed ID: 30138160
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study.
D'Amico E; Chincoli C; Cacciatore P; di Pasqua G; Cosentino L; Riario-Sforza G; Pennese E; Capani F; Palazzi C
Dig Dis Sci; 2005 Dec; 50(12):2344-7. PubMed ID: 16416186
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
12. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
Cornella SL; Stine JG; Kelly V; Caldwell SH; Shah NL
Postgrad Med; 2015 May; 127(4):413-7. PubMed ID: 25746436
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
15. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
16. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review.
Obrișcă B; Jurubiță R; Sorohan B; Iliescu L; Baston C; Bobeică R; Andronesi A; Leca N; Ismail G
Clin Rheumatol; 2019 Dec; 38(12):3677-3687. PubMed ID: 31172367
[TBL] [Abstract][Full Text] [Related]
19. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
Gragnani L; Lorini S; Marri S; Vacchi C; Madia F; Monti M; Ferri C; Zignego AL
Autoimmun Rev; 2022 Jan; 21(1):102923. PubMed ID: 34419670
[TBL] [Abstract][Full Text] [Related]
20. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
